Transmeta Corp. rises despite wider Q4 loss
Shares of Transmeta Corp. (Nasdaq:TMTA), which develops computing, microprocessor and semiconductor technologies, are slightly higher despite news after the close on Monday that fourth-quarter net loss widened. The Santa Clara, Calif.-based company, which added 26 patents in 2007, reported a loss of $23.9 million, or $1.99 per share for the three months ended Dec. 31, 2007, compared with a loss of $12.7 million, or $1.24 per share, a year earlier.
However, Transmeta also said it has resolved a patent dispute with chip maker Intel Corp. (Nasdaq:INTC) and will receive a total of $250 million over the next five years.
At 3:55 p.m. ET, the stock had added $0.61, or 5%, to $13.93. For detailed price information and recent news stories about Insulet, click TMTA.
